vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and STRATTEC SECURITY CORP (STRT). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $137.5M, roughly 1.2× STRATTEC SECURITY CORP). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 5.9%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 7.7%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

STRATTEC Security Corp designs, manufactures and markets mechanical and electronic security access products, including automotive locks, keys, passive entry systems, and trunk release mechanisms. It primarily serves global automotive original equipment manufacturers, heavy-duty vehicle makers, and the automotive aftermarket across North America, Europe and Asia Pacific.

ESPR vs STRT — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.2× larger
ESPR
$168.4M
$137.5M
STRT
Growing faster (revenue YoY)
ESPR
ESPR
+137.9% gap
ESPR
143.7%
5.9%
STRT
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
7.7%
STRT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ESPR
ESPR
STRT
STRT
Revenue
$168.4M
$137.5M
Net Profit
$4.9M
Gross Margin
16.5%
Operating Margin
50.6%
3.5%
Net Margin
3.6%
Revenue YoY
143.7%
5.9%
Net Profit YoY
275.1%
EPS (diluted)
$0.32
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
STRT
STRT
Q4 25
$168.4M
$137.5M
Q3 25
$87.3M
$152.4M
Q2 25
$82.4M
$152.0M
Q1 25
$65.0M
$144.1M
Q4 24
$69.1M
$129.9M
Q3 24
$51.6M
$139.1M
Q2 24
$73.8M
Q1 24
$137.7M
$140.8M
Net Profit
ESPR
ESPR
STRT
STRT
Q4 25
$4.9M
Q3 25
$-31.3M
$8.5M
Q2 25
$-12.7M
$8.3M
Q1 25
$-40.5M
$5.4M
Q4 24
$1.3M
Q3 24
$-29.5M
$3.7M
Q2 24
$-61.9M
Q1 24
$61.0M
$1.5M
Gross Margin
ESPR
ESPR
STRT
STRT
Q4 25
16.5%
Q3 25
17.3%
Q2 25
16.7%
Q1 25
16.0%
Q4 24
13.2%
Q3 24
13.6%
Q2 24
Q1 24
10.4%
Operating Margin
ESPR
ESPR
STRT
STRT
Q4 25
50.6%
3.5%
Q3 25
-11.4%
6.9%
Q2 25
8.6%
5.6%
Q1 25
-34.0%
4.9%
Q4 24
-6.4%
1.6%
Q3 24
-31.0%
3.6%
Q2 24
3.5%
Q1 24
52.5%
1.4%
Net Margin
ESPR
ESPR
STRT
STRT
Q4 25
3.6%
Q3 25
-35.9%
5.6%
Q2 25
-15.4%
5.4%
Q1 25
-62.2%
3.7%
Q4 24
1.0%
Q3 24
-57.2%
2.7%
Q2 24
-83.9%
Q1 24
44.3%
1.1%
EPS (diluted)
ESPR
ESPR
STRT
STRT
Q4 25
$0.32
$1.20
Q3 25
$-0.16
$2.07
Q2 25
$-0.06
$2.02
Q1 25
$-0.21
$1.32
Q4 24
$-0.14
$0.32
Q3 24
$-0.15
$0.92
Q2 24
$-0.33
Q1 24
$0.34
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
STRT
STRT
Cash + ST InvestmentsLiquidity on hand
$167.9M
$99.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$-302.0M
$236.8M
Total Assets
$465.9M
$392.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
STRT
STRT
Q4 25
$167.9M
$99.0M
Q3 25
$92.4M
$90.5M
Q2 25
$86.1M
$84.6M
Q1 25
$114.6M
$62.1M
Q4 24
$144.8M
$42.6M
Q3 24
$144.7M
$34.4M
Q2 24
$189.3M
Q1 24
$226.6M
$9.6M
Stockholders' Equity
ESPR
ESPR
STRT
STRT
Q4 25
$-302.0M
$236.8M
Q3 25
$-451.4M
$230.5M
Q2 25
$-433.5M
$221.6M
Q1 25
$-426.2M
$210.7M
Q4 24
$-388.7M
$204.5M
Q3 24
$-370.2M
$203.0M
Q2 24
$-344.2M
Q1 24
$-294.3M
$193.8M
Total Assets
ESPR
ESPR
STRT
STRT
Q4 25
$465.9M
$392.2M
Q3 25
$364.0M
$390.1M
Q2 25
$347.1M
$391.5M
Q1 25
$324.0M
$387.4M
Q4 24
$343.8M
$355.9M
Q3 24
$314.1M
$366.9M
Q2 24
$352.3M
Q1 24
$373.1M
$348.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
STRT
STRT
Operating Cash FlowLast quarter
$45.2M
$13.9M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
8.2%
Capex IntensityCapex / Revenue
0.0%
1.9%
Cash ConversionOCF / Net Profit
2.81×
TTM Free Cash FlowTrailing 4 quarters
$67.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
STRT
STRT
Q4 25
$45.2M
$13.9M
Q3 25
$-4.3M
$11.3M
Q2 25
$-31.4M
$30.2M
Q1 25
$-22.6M
$20.7M
Q4 24
$-35.0M
$9.4M
Q3 24
$-35.3M
$11.3M
Q2 24
$-7.2M
Q1 24
$53.8M
$-309.0K
Free Cash Flow
ESPR
ESPR
STRT
STRT
Q4 25
$11.3M
Q3 25
$9.8M
Q2 25
$27.2M
Q1 25
$19.6M
Q4 24
$8.5M
Q3 24
$-35.5M
$9.3M
Q2 24
$-7.3M
Q1 24
$53.8M
$-2.0M
FCF Margin
ESPR
ESPR
STRT
STRT
Q4 25
8.2%
Q3 25
6.4%
Q2 25
17.9%
Q1 25
13.6%
Q4 24
6.6%
Q3 24
-68.7%
6.7%
Q2 24
-9.9%
Q1 24
39.0%
-1.4%
Capex Intensity
ESPR
ESPR
STRT
STRT
Q4 25
0.0%
1.9%
Q3 25
0.0%
1.0%
Q2 25
0.0%
2.0%
Q1 25
0.0%
0.8%
Q4 24
0.0%
0.7%
Q3 24
0.3%
1.5%
Q2 24
0.1%
Q1 24
0.1%
1.2%
Cash Conversion
ESPR
ESPR
STRT
STRT
Q4 25
2.81×
Q3 25
1.33×
Q2 25
3.65×
Q1 25
3.84×
Q4 24
7.16×
Q3 24
3.06×
Q2 24
Q1 24
0.88×
-0.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

STRT
STRT

Door Handles And Exterior Trim$35.0M25%
Power Access Solutions$34.5M25%
Keys And Locksets$26.8M19%
Latches$16.3M12%
User Interface Controls$12.5M9%
Aftermarket And Service$9.4M7%
Other Product$3.1M2%
Related Party$1.3M1%

Related Comparisons